Aim adviser Panmure Gordon has obtained a £17.3m cash injection from BlueGem LP.
This sparked a 2.5p rise in the share price to 36.5p, which values Panmure at £27.6m.
BlueGem is paying 24p a share for its 40.3% stake. Marco Capello and Emilio Di Spiezio Sardo will join the board as non-executive directors.
BlueGem is a private equity fund which has made four investments in the UK and Italy.
Panmure’s regulatory capital will be over £40m - more than three times its required regulatory capital - and management hopes that BlueGem will help to introduce the broker to contacts and expertise.
Panmure reported a loss of £28.8m in 2008. The underlying loss was £9.2m, against a 2007 profit of £10.5m. The UK trading loss was £2.2m. Corporate finance income halved. Overall revenues fell from £65.2m to £42.1m. The cash outflow from operations was £16.6m.
UK costs have been reduced by 10% and US costs cut by 18%. The US operation was responsible for most of the 2008 loss, which included a £13.7m write-down on the value of goodwill relating to the US acquisition.
Trading conditions don’t appear to have improved significantly. There are signs of an improvement in the UK, though.
© 2025 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds